000 | 01863 a2200553 4500 | ||
---|---|---|---|
005 | 20250515120659.0 | ||
264 | 0 | _c20080919 | |
008 | 200809s 0 0 eng d | ||
022 | _a0006-8993 | ||
024 | 7 |
_a10.1016/j.brainres.2008.02.073 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOyagi, A | |
245 | 0 | 0 |
_aProtective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease. _h[electronic resource] |
260 |
_bBrain research _cJun 2008 |
||
300 |
_a169-76 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
650 | 0 | 4 |
_aAdrenergic Agents _xtoxicity |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aAniline Compounds _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntioxidants _xtherapeutic use |
650 | 0 | 4 |
_aBody Weight _xdrug effects |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNeuroblastoma _xpathology |
650 | 0 | 4 |
_aOxidopamine _xtoxicity |
650 | 0 | 4 |
_aParkinsonian Disorders _xchemically induced |
650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
700 | 1 | _aOida, Y | |
700 | 1 | _aHara, H | |
700 | 1 | _aIzuta, H | |
700 | 1 | _aShimazawa, M | |
700 | 1 | _aMatsunaga, N | |
700 | 1 | _aAdachi, T | |
700 | 1 | _aHara, H | |
773 | 0 |
_tBrain research _gvol. 1214 _gp. 169-76 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2008.02.073 _zAvailable from publisher's website |
999 |
_c17953625 _d17953625 |